Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Experimental: Seladelpar / MBX-8025 200 mg

[1] Seladelpar 💬

[1] PPARG 💬

[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬

[1] 93 💬

2

Experimental: Seladelpar / MBX-8025 50 mg

[1] Seladelpar 💬

[1] PPARG 💬

[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬

[1] 93 💬

3

-

-

-

-

[3] 79, 93, 94 💬

4

MBX-8025 50 mg (Dose Escalation Period 1)

-

-

-

-

[1] 79 💬

5

MBX-8025 50 mg or 100 mg (Dose Escalation Period 2)

-

-

-

-

[1] 79 💬

6

MBX-8025 50 mg, 100 mg or 200 mg (Dose Escalation Period 3)

-

-

-

-

[1] 79 💬

7

-

-

-

-

[1] 93 💬

8

MBX-8025, Formulation 2

-

-

-

-

[1] 93 💬